Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Evidence strongly supports the important role of insulin resistance in cognitive decline and dementia and suggests that insulin sensitizers may protect against cognitive decline in diabetic and pre-diabetic individuals. Inconclusive results have been reported in clinical trials of rosiglitazone, an insulin sensitizer that also increases cardiovascular mortality risks. No study has yet reported a protective cognitive effect of metformin, an insulin-sensitizing biguanide widely used in diabetic patients. We studied 365 older persons aged 55 and over in the population-based Singapore Longitudinal Aging Study with diabetes who were followed up over 4 years. The odds ratios (OR) of association of metformin use (n = 204) versus non-use (n = 161) with cognitive impairment (Mini-Mental State Exam ≤ 23), and by duration: up to 6 years (n = 114) and more than 6 years (n = 90) were evaluated in cross-sectional and longitudinal multivariate analyses. Controlling for age, education, diabetes duration, fasting blood glucose, vascular and non-vascular risk factors, metformin use showed a significant inverse association with cognitive impairment in longitudinal analysis (OR = 0.49, 95% CI 0.25-0.95). Metformin use showed significant linear trends of association across duration of use in cross-sectional and longitudinal analyses (p = 0.018 and p = 0.002, respectively), with use for more than 6 years significantly associated with lowest risk of cognitive impairment in both cross-sectional anal…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“although some epidemiological studies supported a protective role for metformin, which crosses the BBB, in preventing cognitive decline in individuals with type 2 diabetes [304]”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [304]
In the citing paper
“In the Singapore Longitudinal Aging Study 2,365 subjects with diabetes (age ≥ 55) were monitored for 4 years – see Table 2 (116). In a cross-sectional and longitudinal multivariate analysis, odds ratios of association of the chronic use of metformin with cognitive disability (Mini-Mental State Exam ≤ 23) were evaluated demonstrating a substantial inverse relationship with cognitive impairment (116”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [116]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 2×
“Metformin has also been shown to attenuate inflammation in experimental models of central inflammation by modulating proinflammatory responses in rat primary microglia cells through both AMPK-dependent and AMPK-independent mechanisms [36].”
BackgroundAppendix G: Geriatric Depression Scale
(2015) · Deep Brain Stimulation Management · doi:10.1017/cbo9781316026625.021 · Cited by 1,536
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,286
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084 · cited 1×
“This is responsible for the known effects of metformin in inhibiting hepatic glucose production, increasing insulin sensitivity, enhancing peripheral utilization of glucose (from improved insulin binding to insulin receptors), and increasing fatty acid oxidation [31], leading to improved glycemic and lipid profiles fr…”
BackgroundCognitive decline and dementia in diabetes—systematic overview of prospective observational studies
Cukierman, T., Gerstein, H. C., & Williamson, J. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0023-4 · Cited by 1,049
Risner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686
Watson, G. S. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.950 · Cited by 597
Cited by
Items 101–200 of 359
Metformin in the diabetic brain: friend or foe?
Moreira, P. I. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.06.10 · Cited by 50
Impact of Insulin Sensitizers on the Incidence of Dementia: A Meta-Analysis
Ye, F., Luo, Y.-J., Xiao, J., Yu, N.-W., & Yi, G. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000445941 · Cited by 46
The effect of metformin on cognitive function: A systematic review and meta-analysis
Tabatabaei‐Malazy, O., Bandarian, F., Qorbani, M., Mohseni, S., Mirsadeghi, S., Peimani, M., & Larijani, B. A. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211057304 · Cited by 48
Metformin: new applications for an old drug
Naseri, A., Sanaie, S., Hamzehzadeh, S., Sahebari, S. S., Hosseini, M., Gholipour-khalili, E., Rezazadeh-Gavgani, E., Majidazar, R., Seraji, P., Daneshvar, S., et al. (2022) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2022-0252 · Cited by 46
Luo, A., Ning, P., Lu, H., Huang, H., Shen, Q., Zhang, D., Xu, F., Yang, L. J., & Xu, Y. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220180 · Cited by 45
Metformin and cognition from the perspectives of sex, age, and disease
Chaudhari, K., Reynolds, C. D., & Yang, S.-H. (2020) · GeroScience · doi:10.1007/s11357-019-00146-3 · Cited by 44
Pomilio, C. J., Pérez, N. G., Calandri, I. L., Crivelli, L., Allegri, R., Initiative, T. A. A. D. N., Sevlever, G. E., & Saravia, F. (2022) · GeroScience · doi:10.1007/s11357-022-00568-6 · Cited by 44
Depression, Type 2 Diabetes, and Poststroke Cognitive Impairment
Swardfager, W., & MacIntosh, B. J. (2016) · Neurorehabilitation and neural repair · doi:10.1177/1545968316656054 · Cited by 43
Metformin treatment improves the spatial memory of aged mice in an APOE genotype–dependent manner
Zhang, J., Lin, Y., Dai, X., Fang, W., Wu, X., & Chen, X. (2019) · The FASEB Journal · doi:10.1096/fj.201802718r · Cited by 43
Syal, C., Kosaraju, J., Hamilton, L., Aumont, A., Chu, A., Sarma, S. N., Thomas, J., Seegobin, M., Dilworth, F. J., He, L., et al. (2020) · Theranostics · doi:10.7150/thno.44962 · Cited by 42
Molecular hallmarks of ageing in amyotrophic lateral sclerosis
Jagaraj, C. J., Shadfar, S., Kashani, S. A., Saravanabavan, S., Farzana, F., & Atkin, J. D. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05164-9 · Cited by 42
Koschei the immortal and anti-aging drugs
Blagosklonny, M. V. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.520 · Cited by 42
Infante‐Garcia, C., Ramos‐Rodríguez, J. J., Hierro‐Bujalance, C., Ortegon, E., Pickett, E. K., Jackson, R. J., Pacho, F. H., Spires‐Jones, T. L., & García-Alloza, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0825-7 · Cited by 42
Taheri, A., Emami, M., Asadipour, E., Kasirzadeh, S., Rouini, M. R., Najafi, A., Heshmat, R., Abdollahi, M. R., & Mojtahedzadeh, M. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09366-1 · Cited by 42
Recent Advances in Anti-Aging Medicine
Son, D., Park, W.-J., & Lee, Y. (2019) · Korean Journal of Family Medicine · doi:10.4082/kjfm.19.0087 · Cited by 42
Metabolic Syndrome: Is It Time to Add the Central Nervous System?
Rojas, M., Chávez-Castillo, M., Pírela, D., Parra, H., Nava, M., Chacín, M., Angarita, L., Áñez, R., Salazar, J. J., Ortíz, R., et al. (2021) · Nutrients · doi:10.3390/nu13072254 · Cited by 42
Taming expectations of metformin as a treatment to extend healthspan
Konopka, A. R., & Miller, B. F. (2019) · GeroScience · doi:10.1007/s11357-019-00057-3 · Cited by 42
Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer’s Disease
Zhao, Y., Zhang, Y., Zhang, J., Zhang, X., & Yang, G. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200114163636 · Cited by 41
Soo, S. K., Rudich, P. D., Traa, A., Harris-Gauthier, N., Shields, H. J., & Raamsdonk, J. M. V. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111297 · Cited by 41
Taking metformin and cognitive function change in older patients with diabetes
Koo, B. K., Kim, L., Lee, J., & Moon, M. K. (2019) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13692 · Cited by 40
Teng, Z., Feng, J., Qi, Q., Dong, Y., Xiao, Y., Xie, X., Meng, N., Chen, H.-F., Zhang, W., & Lv, P. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.773797 · Cited by 40
Wennberg, A. M. V., Hagen, C. E., Edwards, K. K., Roberts, R. O., Machulda, M. M., Knopman, D. S., Petersen, R. C., & Mielke, M. M. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4900 · Cited by 40
Hui, E. K., Mukadam, N., Kohl, G., & Livingston, G. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251319054 · Cited by 39
Tan, M. H., Alquraini, H., Mizokami‐Stout, K., & MacEachern, M. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.008 · Cited by 39
Novel targets for delaying aging: The importance of the liver and advances in drug delivery
Hunt, N. J., McCourt, P., Couteur, D. G. L., & Cogger, V. C. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.006 · Cited by 39
Coccaro, E. F., Drossos, T., & Phillipson, L. (2016) · Primary care diabetes · doi:10.1016/j.pcd.2016.05.006 · Cited by 39
Metformin Therapy Aggravates Neurodegenerative Processes in ApoE –/– Mice
Kuhla, A., Brichmann, E., Rühlmann, C., Thiele, R., Meuth, L., & Vollmar, B. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181017 · Cited by 38
A geroscience motivated approach to treat Alzheimer’s disease: Senolytics move to clinical trials
Gonzales, M. M., Krishnamurthy, S., Garbarino, V. R., Daeihagh, A. S., Gillispie, G. J., Deep, G., Craft, S., & Orr, M. E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111589 · Cited by 38
Hurvitz, N., Elkhateeb, N., Sigawi, T., Rinsky‐Halivni, L., & Ilan, Y. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.1044038 · Cited by 38
Metformin monotherapy downregulates diabetes-associated inflammatory status and impacts on mortality
Tizazu, A. M., Nyunt, M. S. Z., Cexus, O., Suku, K., Mok, E., Xian, C. H., Chong, J., Tan, C., How, W., Hubert, S., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00572 · Cited by 37
Self-citationMetformin in the Prevention of Alzheimer's Disease and Alzheimer's Disease Related Dementias
Tahmi, M., & Luchsinger, J. A. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.113 · Cited by 37
Targeting ageing and preventing organ degeneration with metformin
Sunjaya, A. P., & Sunjaya, A. F. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.09.009 · Cited by 37
Glucose regulation and cognitive function after bariatric surgery
Galioto, R., Alosco, M. L., Spitznagel, M. B., Strain, G. W., Devlin, M. J., Cohen, R. A., Crosby, R. D., Mitchell, J. E., & Gunstad, J. (2015) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2015.1023264 · Cited by 37
Some Candidate Drugs for Pharmacotherapy of Alzheimer’s Disease
Miziak, B., Błaszczyk, B., & Czuczwar, S. J. (2021) · Pharmaceuticals · doi:10.3390/ph14050458 · Cited by 37
Promise of metformin for preventing age-related cognitive dysfunction
Shetty, A. K., Madhu, L. N., & Kodali, M. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.320971 · Cited by 36
Nagar, S. D., Pemu, P. I., Qian, J., Boerwinkle, E., Cicek, M. S., Clark, C. R., Cohn, E., Gebo, K. A., Loperena, R., Mayo, K., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-23353-z · Cited by 36
García‐Viñuales, S., Sciacca, M. F. M., Lanza, V., Santoro, A. M., Grasso, G., Tundo, G. R., Sbardella, D., Coletta, M., Grasso, G., Rosa, C. L., et al. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2021.105072 · Cited by 35
Chow, E., Yang, A., Chung, C. H. L., & Chan, J. C. N. (2022) · Pharmaceuticals · doi:10.3390/ph15040442 · Cited by 35
Mechanisms of ageing: growth hormone, dietary restriction, and metformin
Khan, J., Pernicova, I., Nisar, K., & Korbonits, M. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00001-3 · Cited by 35
Sultana, M. A., Hia, R. A., Akinsiku, O., & Hegde, V. K. (2023) · Biology · doi:10.3390/biology12071019 · Cited by 35
Blümel, J. E., Arteaga, E., Aedo, S., Arriola‐Montenegro, J., López, M., Martino, M., Miranda, C., Miranda, O., Mostajo, D., Ñañez, M., et al. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1718092 · Cited by 35
Bali, P., Kaur, N., Tiwari, A., Bammidi, S., Podder, V., Devi, C., Kumar, S., Sivapuram, M. S., Ghani, A., Modgil, S., et al. (2020) · Neuroepidemiology · doi:10.1159/000505816 · Cited by 35
Low, S. K., Ng, T. P., Lim, C. L., Ang, S. F., Moh, A. M. C., Wang, J., Yap, P. L. K., Cheong, C. Y., Goh, K. S., Ang, K., et al. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13104 · Cited by 34
Self-citationPharmacological Approaches Using Diabetic Drugs Repurposed for Alzheimer’s Disease
Adem, M. A., Decourt, B., & Sabbagh, M. N. (2024) · Biomedicines · doi:10.3390/biomedicines12010099 · Cited by 34
Human Aging and Age-Related Diseases: From Underlying Mechanisms to Pro-Longevity Interventions
Chmielewski, P. P., Data, K., Strzelec, B., Farzaneh, M., Anbiyaiee, A., Zaheer, U., Uddin, S., Sheykhi-Sabzehpoush, M., Mozdziak, P. E., Zabel, M., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0280 · Cited by 34
Exercise-Pharmacology Interactions: Metformin, Statins, and Healthspan
Miller, B. F., & Thyfault, J. P. (2020) · Physiology · doi:10.1152/physiol.00013.2020 · Cited by 33
Peng, L., Fang, X., Xu, F., Liu, S., Qian, Y., Gong, X., Zhao, X., Ma, Z., Xia, T., & Gu, X. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.686506 · Cited by 34
Ostroumova, O. D., Surkova, E. V., Chikh, E. V., Rebrova, E. V., & Borisov, M. S. (2018) · Diabetes Mellitus · doi:10.14341/dm9660 · Cited by 32
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Yip, J., Chiang, G. S. H., Lee, I. C. J., Lehming-Teo, R., Dai, K., Dongol, L., Wang, L. Y.-T., Teo, D. W. X., Seah, G. T., & Lehming, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010364 · Cited by 31
Battini, V., Cirnigliaro, G., Leuzzi, R., Rissotto, E., Mosini, G., Benatti, B., Pozzi, M., Nobile, M., Radice, S., Carnovale, C., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1215807 · Cited by 31
Gorgich, E. A. C., Parsaie, H., Yarmand, S., Baharvand, F., & Sarbishegi, M. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113343 · Cited by 32
The Roles of Apolipoprotein E, Lipids, and Glucose in the Pathogenesis of Alzheimer’s Disease
Shinohara, M., & Sato, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_5 · Cited by 30
Anti-Aging Effect of Metformin: A Molecular and Therapeutical Perspective
Torres, W., Nava, M., Galbán, N., Gómez, Y., Morillo, V., Rojas, M., Cano, C., Chacín, M., D’Marco, L., Herazo-Beltrán, Y., et al. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200716161610 · Cited by 30
Subba, R., Ahmad, M. H., Ghosh, B., & Mondal, A. C. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174993 · Cited by 30
Sadeer, N. B., Sinan, K. I., Cziáky, Z., Jekő, J., Zengin, G., Jeewon, R., Abdallah, H. H., Al-Dhaheri, Y., Eid, A. H., & Mahomoodally, M. F. (2022) · Molecules · doi:10.3390/molecules27062000 · Cited by 30
Metformin: Repurposing Opportunities for Cognitive and Mood Dysfunction
Ying, M., Maruschak, N., Mansur, R., Carvalho, A., Cha, D., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130205514 · Cited by 29
Defects of Nutrient Signaling and Autophagy in Neurodegeneration
Ondaro, J., Hernández-Eguiazu, H., Garciandia-Arcelus, M., Loera‐Valencia, R., Rodríguez-Gómez, L., Jiménez-Zúñiga, A., Goikolea, J., Rodriguez‐Rodriguez, P., Ruiz‐Martínez, J., Moreno, F., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.836196 · Cited by 29
Role of Peripheral and Central Insulin Resistance in Neuropsychiatric Disorders
Alagiakrishnan, K., & Halverson, T. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216607 · Cited by 28
A Review on Metformin: Clinical Significance and Side Effects
Mazumder, A., & Ashini, S. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.01070 · Cited by 28
AMPK Activator O304 Protects Against Kidney Aging Through Promoting Energy Metabolism and Autophagy
Zhu, M., Shen, W., Li, J., Jia, N., Xiong, Y., Miao, J., Xie, C., Chen, Q., Shen, K., Meng, P., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.836496 · Cited by 28
Stevenson‐Hoare, J. O., Leonenko, G., & Escott‐Price, V. (2023) · BMC Public Health · doi:10.1186/s12889-023-15764-y · Cited by 28
Dysmetabolism and Neurodegeneration: Trick or Treat?
Capucho, A. M., Chegão, A., Martins, F. O., Miranda, H. V., & Conde, S. V. (2022) · Nutrients · doi:10.3390/nu14071425 · Cited by 28
Nibber, A., Singh, H., Burnet, P., Lennox, B., & Minichino, A. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.04.156 · Cited by 27
Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease
Fülöp, T., Tripathi, S., Rodrigues, S., Desroches, M., Bunt, T., Eiser, A. R., Bernier, F., Beauregard, P. B., Barron, A. E., Khalil, A., et al. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s264910 · Cited by 27
Ayoub, S., Arabi, M., Al-Najjar, Y. A., Laswi, I., Outeiro, T. F., & Châari, A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05051-9 · Cited by 27
Le vieillissement du système immunitaire : du fondamental à la clinique
Vallet, H., Fali, T., & Sauce, D. (2018) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2018.07.005 · Cited by 26
Metformin and the risk of dementia based on an analysis of 396,332 participants
Ji, S., Zhao, X., Zhu, R., Dong, Y., Huang, L., & Zhang, T. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221109454 · Cited by 26
Antiaging Therapies, Cognitive Impairment, and Dementia
Wahl, D., Anderson, R. M., & Couteur, D. G. L. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz135 · Cited by 27
Targeting Myotonic Dystrophy Type 1 with Metformin
García-Puga, M., Saenz‐Antoñanzas, A., Matheu, A., & de Munaín, A. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052901 · Cited by 26
Inoue, Y., Masuda, T., Misumi, Y., Ando, Y., & Ueda, M. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136136 · Cited by 25
Zhang, Y., Zhang, Y., Shi, X., Han, J., Lin, B., Peng, W., Mei, Z., & Yang, L. (2022) · Diabetic Medicine · doi:10.1111/dme.14821 · Cited by 25
Liu, J., Zhang, M., Deng, D., & Zhu, X. M. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01445-2 · Cited by 25
Aljanabi, N. M., Mamtani, S. S., Al-Ghuraibawi, M. M. H., Yadav, S. K., & Nasr, L. A. (2020) · Cureus · doi:10.7759/cureus.6885 · Cited by 25
Hong, S., Nagayach, A., Lü, Y., Peng, H., Duong, Q.-V., Pham, N. B., Vuong, C. A., & Bazan, N. G. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13726 · Cited by 25
Emerging role of Metformin in Alzheimer’s disease: A translational view
Ríos, J. A., Bórquez, J. C., Godoy, J. A., Zolezzi, J. M., Furrianca, M. C., & Inestrosa, N. C. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102439 · Cited by 24
The neurobiology of the Prader-Willi phenotype of fragile X syndrome
Muzar, Z., Lozano, R., Kolevzon, A., & Hagerman, R. J. (2016) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2016.01082 · Cited by 22
Diabetes Therapies for Dementia
Moran, C., Callisaya, M. L., Srikanth, V. K., & Arvanitakis, Z. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-0973-4 · Cited by 24
Metformin reduces prion infection in neuronal cells by enhancing autophagy
Abdelaziz, D. H., Thapa, S., Abdulrahman, B., Vankuppeveld, L., & Schätzl, H. M. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.12.074 · Cited by 24
Glucose-lowering drugs, cognition, and dementia: The clinical evidence
Wu, C., Shapiro, L. R., Ouk, M., MacIntosh, B. J., Black, S. E., Shah, B. R., & Swardfager, W. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104654 · Cited by 24
Indarto, I., Widiyanto, A., & Atmojo, J. T. (2023) · Jurnal Ilmiah Permas Jurnal Ilmiah STIKES Kendal · doi:10.32583/pskm.v13i2.852 · Cited by 23
Metformin Use and Cognitive Dysfunction Among Patients with Diabetes Mellitus
Liccini, A. P., Malmstrom, T. K., & Morley, J. E. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.08.026 · Cited by 23
Therapeutic Strategies for Alzheimer’s Disease in the View of Diabetes Mellitus
Ohyagi, Y., Miyoshi, K., & Nakamura, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_11 · Cited by 23
Hartman, S. J., Nelson, S. H., Marinac, C. R., Natarajan, L., Parker, B. A., & Patterson, R. E. (2019) · Psycho-Oncology · doi:10.1002/pon.5129 · Cited by 23
Su, K., & Dai, C. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2291-1 · Cited by 23
Masters, M. C., Perez, J., Wu, K., Ellis, R. J., Goodkin, K., Koletar, S. L., Andrade, A. S., Yang, J., Brown, T. T., Palella, F. J., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab122 · Cited by 22
Metformin, Cognitive Decline, And Brain Pathology
Sood, A., Capuano, A. W., Wilson, R. S., Barnes, L. L., Kapasi, A., Bennett, D. A., & Arvanitakis, Z. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.10.005 · Cited by 22
Novel targets and therapies of metformin in dementia: old drug, new insights
Cui, W., Lv, C., Geng, P., Fu, M., Zhou, W., Xiong, M., & Li, T. X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1415740 · Cited by 22
Moh, M. C., Low, S. K., Ng, T. P., Wang, J., Ang, S. F., Tan, C. S. H., Ang, K., Subramaniam, T., Sum, C. F., Kwan, P. Y., et al. (2020) · Clinical Obesity · doi:10.1111/cob.12352 · Cited by 22
Self-citationKumari, S., Bubak, M. P., Schoenberg, H. M., Davidyan, A., Elliehausen, C. J., Kuhn, K. G., VanWagoner, T. M., Karaman, R., Scofield, R. H., Miller, B. F., et al. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab358 · Cited by 22
Effect of Tanshinone IIA on Gut Microbiome in Diabetes-Induced Cognitive Impairment
Zheng, Y., Zhou, X., Wang, C., Zhang, J., Chang, D., Liu, W., Zhu, M.-X., Zhuang, S., Shi, H., Wang, X., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.890444 · Cited by 22
Karami, F., Jamaati, H., Coleman‐Fuller, N., Zeini, M. S., Hayes, A. W., Gholami, M., Salehirad, M., Darabi, M., & Motaghinejad, M. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00469-1 · Cited by 21
The development and benefits of metformin in various diseases
Dong, Y., Qi, Y., Jiang, H., Tian, M., Zhang, Y., Peng, C. S., Li, W.-C., Zhang, Y., Zhou, Y., Zang, Y., et al. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-0998-6 · Cited by 21
Zhuge, F., Zheng, L., Pan, Y., Ni, L., Fu, Z., Shi, J., & Ni, Y. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114689 · Cited by 21
Morley, J. E. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.111 · Cited by 21
Sečník, J., Xu, H., Schwertner, E., Hammar, N., Alvarsson, M., Winblad, B. G., Eriksdotter, M., Ptacek, S. G., & Religa, D. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200618 · Cited by 21
Self-citationTian, L., Ri, H.-P., Qi, J., & Fu, P. (2021) · Molecular Pain · doi:10.1177/1744806921996101 · Cited by 21
RetractedKioussis, B., Tuttle, C. S. L., Heard, D. S., Kennedy, B. K., Lautenschlager, N. T., & Maier, A. B. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101302 · Cited by 21
Using human experience to identify drug repurposing opportunities: theory and practice
Cavalla, D. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13851 · Cited by 21
Management of Comorbidities in Older Persons With Type 2 Diabetes
Morley, J. E., Abbatecola, A. M., & Woo, J. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.05.006 · Cited by 21
Sweet Mitochondria: A Shortcut to Alzheimer’s Disease
Moreira, P. I. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170931 · Cited by 20
Metadata
- Authors
- Ng, T. P., Feng, L., Yap, K. B., Lee, T. S., Tan, C. H., & Winblad, B.
- Affiliations
- National University of Singapore (SG)
- Karolinska Institutet (SE)
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2014-06-04
- Volume
- 41
- Issue
- 1
- Pages
- 61-68
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1597817261
- Cited by
- 334
- References
- 35
- Citations by year
- 2026: 17 · 2025: 17 · 2024: 36 · 2023: 33 · 2022: 35 · 2021: 39 · 2020: 42 · 2019: 41 · 2018: 23 · 2017: 14 · 2016: 19 · 2015: 12 · 2014: 6
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- metformin, cognitive impairment
- MeSH terms
- Aged, Aged, 80 and over, Cognition Disorders, Cross-Sectional Studies, Diabetes Mellitus, Female, Humans, Hypoglycemic Agents, Longitudinal Studies, Male, Metformin, Middle Aged, Prospective Studies, Singapore, Time Factors, Multivariate Analysis, Linear Models, Odds Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.